Related Experiment Video
Updated: Aug 5, 2026
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Update on Clostridioides difficile Infection in Older Adults
1Geriatric Research Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Clinics in Geriatric Medicine
|August 3, 2026
Summary
Clostridioides difficile infection (CDI) significantly impacts older adults, especially in long-term care facilities (LTCFs). This review covers the latest understanding of CDI epidemiology, diagnosis, and management in this vulnerable population.
Area of Science:
- Geriatrics
- Infectious Diseases
- Epidemiology
Background:
- Clostridioides difficile infection (CDI) is a frequent cause of community- and healthcare-associated infections.
- Older adults experience a disproportionate burden of CDI, particularly within long-term care facilities (LTCFs).
- Recurrent CDI in older individuals leads to significant declines in quality of life.
Purpose of the Study:
- To review current concepts in the epidemiology of Clostridioides difficile infection (CDI) in older adults.
- To discuss contemporary diagnostic approaches for CDI in the geriatric population.
- To outline current management strategies for CDI in older adults, considering community and LTCF settings.
Main Methods:
- Literature review of recent studies on Clostridioides difficile infection (CDI).
- Focus on epidemiological data, diagnostic advancements, and therapeutic guidelines relevant to older adults.
- Synthesis of information pertaining to both community-acquired and healthcare-associated CDI.
Main Results:
- Older adults face higher risks and more severe outcomes from CDI.
- Effective diagnosis and timely management are crucial for improving patient outcomes and reducing recurrence.
- Long-term care facilities are key settings for CDI prevention and control efforts.
Conclusions:
- Clostridioides difficile infection (CDI) presents unique challenges in older adults due to increased susceptibility and recurrence rates.
- Optimizing diagnostic testing and management strategies is essential for mitigating the impact of CDI in this demographic.
- Continued research and implementation of evidence-based practices are needed to address the burden of CDI in older populations.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...